ViiV Culture=Backstabbing

Discussion in 'GlaxoSmithKline' started by anonymous, Aug 6, 2018 at 12:04 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Actually, the fact that GSK/ViiV does not pay, promote, or evaluate us on hard sales numbers is why I love this job.

    You are on easy street by taking care of the RSD, padding the metrics, doing the occasional dinner program, weekly lunch, and not making waves.

    I know that the handful of accessible docs who are going to use DTG/3TC are the same ones who tried Juluca. My pod has more writers than most but that is purely luck and not effort.

    There is so much time in this job to work on other revenue streams and side businesses. Best. Job. In. Pharma!
     

  2. anonymous

    anonymous Guest

    everybody has their price and pathetically yours is is very low. Ever heard of having pride in your work?
     
  3. anonymous

    anonymous Guest

    Colleen P, Marlon P, and the retirements and resignations including our most recent open leader who quit (openly gay which was nice) shows that ViiV is just another drug company. That is not bad in upon itself if money is the goal. At ViiV we pretend. Once ViiV can make money off of another disease, sisters and brothers buh-bye.
     
  4. anonymous

    anonymous Guest

    Wait until our Dovato numbers roll in well under even our companies subdued goals - 3 pod mates to 1?
     
  5. anonymous

    anonymous Guest

    where did the latest guy go?